BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 27843047)

  • 1. A prospective study on the impact of heart rate control achieved with metoprolol on cardiac performance, motor function and quality of life in Chinese chronic heart failure patients.
    Meng Y; Liu X; Liu J; Cheng X
    Int J Cardiol; 2017 Jan; 227():267-271. PubMed ID: 27843047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in quality of life of Chinese chronic heart failure patients with neuropsychiatric complications over 12-months post-treatment with metoprolol.
    Zhang R; Huang J; Shu Q; Wu L; Zhang Q; Meng Y
    Medicine (Baltimore); 2019 Jan; 98(4):e14252. PubMed ID: 30681618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-dependent changes in physical, mental, and quality of life outcomes in metoprolol-treated Chinese chronic heart failure patients.
    Wu L; Zhang Q; Shu Q; Zhang R; Meng Y
    Medicine (Baltimore); 2019 Dec; 98(50):e18331. PubMed ID: 31852127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-dependent changes in cardiac performance, motor function, QoL, and mental status in metoprolol-treated chronic heart failure patients.
    Shu Q; Wu L; Zhang R; Zhang Q; Huang J; Meng Y
    Sci Rep; 2019 Jan; 9(1):453. PubMed ID: 30679746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of metoprolol treatment on cardiac function and exercise tolerance in heart failure patients with neuropsychiatric disorders.
    Huang J; Zhang R; Liu X; Meng Y
    Curr Med Res Opin; 2018 Jan; 34(1):141-148. PubMed ID: 28532169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Metoprolol in Improving Cardiac and Motor Functions in Patients with Chronic Heart Failure: A Prospective Study.
    Cheng X; Zhu M; Liu Q; Feng Z; Meng Y
    Drug Des Devel Ther; 2020; 14():3485-3494. PubMed ID: 32921985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of metoprolol treatment on mental status of chronic heart failure patients with neuropsychiatric disorders.
    Liu X; Lou X; Cheng X; Meng Y
    Drug Des Devel Ther; 2017; 11():305-312. PubMed ID: 28182127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-independent influence of metoprolol on cardiac and motor functions, QoL, and mental status in Chinese patients with CHF.
    Zhang Q; Shu Q; Wu L; Zhang R; Meng Y
    Ther Clin Risk Manag; 2019; 15():23-31. PubMed ID: 30588002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF).
    Gullestad L; Wikstrand J; Deedwania P; Hjalmarson A; Egstrup K; Elkayam U; Gottlieb S; Rashkow A; Wedel H; Bermann G; Kjekshus J;
    J Am Coll Cardiol; 2005 Jan; 45(2):252-9. PubMed ID: 15653024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart rate control in patients with chronic atrial fibrillation and heart failure.
    Silvet H; Hawkins LA; Jacobson AK
    Congest Heart Fail; 2013; 19(1):25-8. PubMed ID: 22958623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic effects of amiodarone and metoprolol on chronic heart failure complicated by ventricular arrhythmia].
    Lü HS; He BB; Huang GH
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jun; 29(6):1240-2. PubMed ID: 19726373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of metoprolol CR/XL on remodeling of the heart and cardiac rhythm disturbances after myocardial infarction in patients with chronic heart failure].
    Syrkin AL; Poltavskaia MG; Shumilova KM; Ivanov GG; Churganova LIu; Sheianov MV; Gavril'eva SA
    Kardiologiia; 2003; 43(6):48-53. PubMed ID: 12891311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study).
    Shelton RJ; Clark AL; Goode K; Rigby AS; Houghton T; Kaye GC; Cleland JG
    Heart; 2009 Jun; 95(11):924-30. PubMed ID: 19282313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of heart rate recovery to psychological distress and quality of life in patients with chronic heart failure.
    von Känel R; Saner H; Kohls S; Barth J; Znoj H; Saner G; Schmid JP
    Eur J Cardiovasc Prev Rehabil; 2009 Dec; 16(6):645-50. PubMed ID: 19801939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ivabradine improves quality of life in subjects with chronic heart failure compared to treatment with β-blockers: results of a multicentric observational APULIA study.
    Riccioni G; Masciocco L; Benvenuto A; Saracino P; De Viti D; Massari F; Meliota G; Buta F; Speziale G
    Pharmacology; 2013; 92(5-6):276-80. PubMed ID: 24296869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma concentration of Fas/Fas ligand and left ventricular function in response to metoprolol in conjunction with standard treatment.
    Hou YP; Wu JL; Fan Q; Liu MB; Yin BL; Zhang L
    Clin Sci (Lond); 2007 Mar; 112(5):299-304. PubMed ID: 17020540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Ivabradine on Heart Rate and Duration of Exercise in Patients With Mild-to-Moderate Mitral Stenosis: A Randomized Comparison With Metoprolol.
    Saggu DK; Narain VS; Dwivedi SK; Sethi R; Chandra S; Puri A; Saran RK
    J Cardiovasc Pharmacol; 2015 Jun; 65(6):552-4. PubMed ID: 25636072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital-based and telemonitoring guided home-based training programs: effects on exercise tolerance and quality of life in patients with heart failure (NYHA class III) and cardiac resynchronization therapy. A randomized, prospective observation.
    Smolis-Bąk E; Dąbrowski R; Piotrowicz E; Chwyczko T; Dobraszkiewicz-Wasilewska B; Kowalik I; Kazimierska B; Jędrzejczyk B; Smolis R; Gepner K; Maciąg A; Sterliński M; Szwed H
    Int J Cardiol; 2015 Nov; 199():442-7. PubMed ID: 26276068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of cardiac resynchronisation therapy on physical ability and quality of life in patients with chronic heart failure.
    Kloch Badełek M; Klocek M; Czarnecka D; Wojciechowska W; Wiliński J; Kawecka Jaszcz K
    Kardiol Pol; 2012; 70(6):581-8. PubMed ID: 22718376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.